Wong EY, Keeffe JE, Rait JL, Vu HT, Le A, McCarty PhD C, et al. Detection of undiagnosed glaucoma by eye health professionals. Ophthalmology. 2004;111:1508–14.
Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull world health Organ. 2004;82:844–51.
PubMed PubMed Central Google Scholar
Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96:614–8.
Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV. et al.Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis.Lancet Glob Health. 2017;5:e1221–34.
The Department of Health. Australia Government. Visual impairment and blindness in Australia, Dec 2008. https://www.aihw.gov.au/getmedia/fc608984-1c92-48d0-b9fc-1ced9acec3ee/bulletin27.pdf.aspx?inline=true#:~:text=The%20leading%20causes%20of%20blindness,%25)%20and%20cataract%20(12%25). (accessed March 2023).
Rotchford AP, Kirwan JF, Muller MA, Johnson GJ, Roux P. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology. 2003;110:376–82.
Soh Z, Yu M, Betzler BK, Majithia S, Thakur S, Tham YC, et al. The global extent of undetected glaucoma in adults: a systematic review and meta-analysis. Ophthalmology. 2021;128:1393–404.
Chua J, Baskaran M, Ong PG, Zheng Y, Wong TY, Aung T, et al. Prevalence, risk factors, and visual features of undiagnosed glaucoma: the Singapore epidemiology of eye diseases study. JAMA Ophthalmol. 2015;133:938–46.
Topouzis F, Coleman AL, Harris A, Koskosas A, Founti P, Gong G, et al. Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki eye study. Am J Ophthalmol. 2008;145:327–35.e1.
Shaikh Y, Yu F, Coleman AL. Burden of undetected and untreated glaucoma in the United States. Am J Ophthalmol. 2014;158:1121–9.e1.
Sakata K, Sakata LM, Sakata VM, Santini C, Hopker LM, Bernardes R, et al. Prevalence of glaucoma in a South brazilian population: projeto glaucoma. Investig Ophthalmol Vis Sci. 2007;48:4974–9.
Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne visual impairment project. Ophthalmology. 1998;105:733–9.
Article CAS PubMed Google Scholar
Foreman J, Xie J, Keel S, Ang GS, Lee PY, Bourne R, et al. Prevalence and causes of unilateral vision impairment and unilateral blindness in Australia: the National Eye Health Survey. JAMA Ophthalmol. 2018;136:240–8.
Article PubMed PubMed Central Google Scholar
Keel S, Xie J, Foreman J, Lee PY, Alwan M, Fahy ET, et al. Prevalence of glaucoma in the Australian national eye health survey. Br J Ophthalmol. 2019;103:191–5.
O'neill EC, Danesh-Meyer HV, Kong GX, Hewitt AW, Coote MA, Mackey DA, et al. Optic disc evaluation in optic neuropathies: the optic disc assessment project. Ophthalmology. 2011;118:964–70.
Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. Bmj. 2005;331:134.
Article PubMed PubMed Central Google Scholar
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. Jama. 2014;311:1901–11.
Article PubMed PubMed Central Google Scholar
Chan HH, Ong DN, Kong YX, O'Neill EC, Pandav SS, Coote MA, et al. Glaucomatous optic neuropathy evaluation (GONE) project: the effect of monoscopic versus stereoscopic viewing conditions on optic nerve evaluation. Am J Ophthalmol. 2014;157:936–44.
Weinreb RN, Leung CKS, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, et al. Primary open-angle glaucoma. Nat Rev Dis Prim Engl. 2016;2:16067.
Iyer J, Vianna JR, Chauhan BC, Quigley HA. Toward a new definition of glaucomatous optic neuropathy for clinical research. Curr Opin Ophthalmol. 2020;31:85–90.
Chauhan BC, O'leary N, AlMobarak FA, Reis A, Yang H, Sharpe GP, et al. Enhanced detection of open-angle glaucoma with an anatomically accurate optical coherence tomography-derived neuroretinal rim parameter. Ophthalmology. 2013;120:535–43.
Jampel HD, Singh K, Lin SC, Chen TC, Francis BA, Hodapp E, et al. Assessment of visual function in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118:986–1002.
Khoury JM, Donahue SP, Lavin PJ, Tsai JC. Comparison of 24-2 and 30-2 perimetry in glaucomatous and nonglaucomatous optic neuropathies. J Neuroophthalmol. 1999;19:100–8.
Article CAS PubMed Google Scholar
Yenice O, Temel A. Evaluation of two Humphrey perimetry programs: full threshold and SITA standard testing strategy for learning effect. Eur J Ophthalmol. 2005;15:209–12.
Article CAS PubMed Google Scholar
Chauhan BC, Garway-Heath DF, Goñi FJ, Rossetti L, Bengtsson B, Viswanathan AC, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92:569–73.
Article CAS PubMed Google Scholar
Crabb DP, Garway-Heath DF. Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach. Investig Ophthalmol Vis Sci. 2012;53:2770–6.
Garway-Heath DF, Quartilho A, Prah P, Crabb DP, Cheng Q, Zhu H. Evaluation of visual field and imaging outcomes for glaucoma clinical trials (an American Ophthalomological Society Thesis). Trans Am Ophthalmol Soc. 2017;115:115.
The Commonwealth Fund. International Profiles of Health Care Systems. Available at https://www.commonwealthfund.org/international-health-policy-center/system-profiles. Accessed 20 Jul 2023.
Australian Institute of Health and Welfare (2023) Cancer screening programs: quarterly data, AIHW, Australian Government, https://www.aihw.gov.au/reports/cancer-screening/national-cancer-screening-programs-participation/contents/summary (Accessed 20 Jul 2023).
Optometry Australia. http://archived.optometry.org.au/blog-news/2018/8/24/medicare-a-highlight-in-100-years-of-milestones/ Accessed 27 Jan 2022.
Optometry Board of Australia. https://www.optometry.org.au/workforce/australian-optometrists-top-6000-and-two-thirds-are-therapeutically-endorsed/. Accessed 4 Feb 2022.
Optometry Australia. A decade on the PBS and nearly 100,000 scripts a year. https://www.optometry.org.au/therapeutics/a-decade-on-the-pbs-and-nearly-100000-scripts-a-year/. Accessed 25 Jul 2023
Optometry Board of Australia. Optometry Guidelines for Use of Scheduled Medicines. 2018. https://nla.gov.au/nla.obj-2996351198/view (accessed 13 March 2023).
Evidence reviews for selective laser trabeculoplasty in ocular hypertension or chronic open-angle glaucoma adult patients: Glaucoma: diagnosis and management: Evidence review A. London: National Institute for Health and Care Excellence (NICE); 2022.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393:1505–16.
Article PubMed PubMed Central Google Scholar
Australian Government Department of Health. MBS Online: Medicare Benefits Schedule. 2020. http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Downloads-202001. Accessed 26 Apr 2022.
Ford BK, Kim D, Keay L, White AJ. Glaucoma referrals from primary care and subsequent hospital management in an urban Australian hospital. Clin Exp Optom. 2020;103:821–9.
Foot B, MacEwen C. Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome. Eye. 2017;31:771–5.
Article CAS PubMed PubMed Central Google Scholar
Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020;12:e11686.
PubMed PubMed Central Google Scholar
Kirkman JM, Bentley SA, Armitage JA, Woods CA. Could adoption of the rural pipeline concept redress Australian optometry workforce issues? Clin Exp Optom. 2019;102:566–70.
Keeffe JE, Weih LM, McCarty CA, Taylor HR. Utilisation of eye care services by urban and rural Australians. Br J Ophthalmol. 2002;86:24–7.
Article PubMed PubMed Central Google Scholar
Burr J, Mowatt G, Hernández R, Siddiqui M, Cook J, Lourenco T, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess. 2007;11:1–190.
US Preventive Services Task F, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, et al. Screening for primary open-angle glaucoma: US preventive services task force recommendation statement. JAMA. 2022;327:1992–7.
Toomey M, Ho KC, Gyawali R, Stapleton F, Wiles L, Hibbert P, et al. The appropriateness of and barriers to glaucoma care delivery by Australian optometrists. Clin Exp Optom. 2022;105:1–9.
Elam AR, Andrews C, Musch DC, Lee PP, Stein JD. Large disparities in receipt of glaucoma care between enrollees in Medicaid and those with commercial health insurance. Ophthalmology. 2017;124:1442–8.
Stein JD, Talwar N, LaVerne AM, Nan B, Lichter PR. Racial disparities in the use of ancillary testing to evaluate individuals with open-angle glaucoma. Arch Ophthalmol. 2012;130:1579–88.
留言 (0)